Explore the full directors' dealings record of 羚锐制药, a listed equity based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €11.7bn. The latest transaction was disclosed on 24 May 2024 (Sale). Among the most active insiders: 吴希振. Every trade is free.